CV

Chad A. VanHuis

LY Lycera: 14 patents #3 of 35Top 9%
Merck: 5 patents #2,116 of 9,382Top 25%
University of Michigan: 1 patents #1,906 of 4,352Top 45%
Overall (All Time): #318,378 of 4,157,543Top 8%
15
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11059796 Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Thomas D. Aicher, Clarke B. Taylor 2021-07-13
10745364 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, William D. Thomas, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more 2020-08-18
10611740 Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Thomas D. Aicher, Clarke B. Taylor 2020-04-07
10556898 Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease Thomas D. Aicher, Fernando Padilla, Donald J. Skalitzky, Peter L. Toogood 2020-02-11
10442798 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Thomas D. Aicher, Clarke B. Taylor 2019-10-15
10421751 Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Thomas D. Aicher, Clarke B. Taylor 2019-09-24
10364237 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Thomas D. Aicher, Clarke B. Taylor 2019-07-30
10221146 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, William D. Thomas, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more 2019-03-05
9932313 Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Gary D. Glick, Alexander R. Hurd, Clarke B. Taylor 2018-04-03
9896441 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Thomas D. Aicher, Clarke B. Taylor 2018-02-20
9815791 Alkylpyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Donald J. Skalitzky 2017-11-14
9809561 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, William D. Thomas, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more 2017-11-07
9783511 Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Thomas D. Aicher, John MacLean, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +6 more 2017-10-10
9663502 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, John MacLean, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +9 more 2017-05-30
9580388 Pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Gary D. Glick, Alexander R. Hurd, Clarke B. Taylor 2017-02-28